Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Foley, Peter
- Reich, Kristian 6
- Gordon, Kenneth B 4
- Armstrong, April W 3
- Blauvelt, Andrew 3
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
- Gordon, Kenneth B
- Foley, Peter
- Krueger, James G
- Pinter, Andreas
- Reich, Kristian
- Vender, Ronald
- Vanvoorden, Veerle
-
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
- Deleuran, Mette
- Thaçi, Diamant
- Beck, Lisa A
- de Bruin-Weller, Marjolein
- Blauvelt, Andrew
- Forman, Seth
- Bissonnette, Robert
-
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
- Leonardi, Craig
- Reich, Kristian
- Foley, Peter
- Torii, Hideshi
- Gerdes, Sascha
- Guenther, Lyn
- Gooderham, Melinda
-
-
-
-
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- Gordon, Kenneth B
- Strober, Bruce
- Lebwohl, Mark
- Augustin, Matthias
- Blauvelt, Andrew
- Poulin, Yves
- Papp, Kim A